Position in FLGT
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$197,080
New position
Shares Held
12,395
first reported quarter
Ownership
0.044%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 53.86042759177088.ToString("F0")%
Shared 0.ToString("F0")%
None 46.13957240822912.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Inscription Capital, LLC holds $5,410,866 across 12 Diagnostics & Research names. FLGT ranks #11 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
9,772 | $1,204,496 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,241 | $697,305 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
3,438 | $593,055 | |
| 4 | LH |
Labcorp Holdings Inc.
|
1,945 | $518,945 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
3,023 | $515,542 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
844 | $414,851 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,801 | $352,959 | |
| 8 | A |
Agilent Technologies, Inc.
|
2,795 | $318,574 |
All Filings in FLGT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $197,080 | 12,395 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||